Abstract

Evidence is presented to indicate the significance of the shipping containers for commercial sorbitol solutions used in the formulation of liquid dosage forms. Some inconsistency in stability data of ascorbic acid formulations is attributed to the relatively high trace metal content of the sorbitol solution used. This solution was supplied in a poorly protected metal container.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call